Cargando…
Systemic vs. Topical Therapy for the Treatment of Vulvovaginal Candidiasis
It is estimated that 75% of all women will experience at least 1 episode of vulvovaginal candidiasis (VVC) during their lifetimes. Most patients with acute VVC can be treated with short-term regimens that optimize compliance. Since current topical and oral antifungals have shown comparably high effi...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
1994
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364342/ https://www.ncbi.nlm.nih.gov/pubmed/18475346 http://dx.doi.org/10.1155/S1064744994000098 |